Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 9536091)

Published in Hum Mol Genet on May 01, 1998

Authors

S Chang1, M J Rosenberg, H Morton, C A Francomano, L G Biesecker

Author Affiliations

1: Laboratory of Genetic Disease Research and Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Articles by these authors

Conservation of the Caenorhabditis elegans timing gene clk-1 from yeast to human: a gene required for ubiquinone biosynthesis with potential implications for aging. Mamm Genome (1999) 9.96

Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet (1992) 5.20

The skipping of constitutive exons in vivo induced by nonsense mutations. Science (1993) 4.41

Career development for women in academic medicine: Multiple interventions in a department of medicine. JAMA (1996) 3.14

The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Endocr Rev (2000) 2.59

Positional cloning of a novel gene on chromosome 16q causing Bardet-Biedl syndrome (BBS2). Hum Mol Genet (2001) 2.56

Mutations in MKKS cause Bardet-Biedl syndrome. Nat Genet (2000) 2.45

Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet (1995) 2.43

Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. Genomics (1993) 2.43

Software for constructing and verifying pedigrees within large genealogies and an application to the Old Order Amish of Lancaster County. Genome Res (1998) 2.41

A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat Genet (1995) 2.30

GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. Nat Genet (1997) 2.28

Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci U S A (1992) 2.26

Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia. Nat Genet (1995) 2.25

A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet (1997) 2.22

Considerations for a multiaxis nomenclature system for medical genetics. Genet Med (2001) 2.15

Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. Am J Hum Genet (1995) 2.01

Mutation of a gene encoding a putative chaperonin causes McKusick-Kaufman syndrome. Nat Genet (2000) 1.99

Characterization of short tandem repeats from thirty-one human telomeres. Genome Res (1997) 1.96

A GNAS1 imprinting defect in pseudohypoparathyroidism type IB. J Clin Invest (2000) 1.93

L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor. Can J Physiol Pharmacol (1989) 1.88

A novel nemaline myopathy in the Amish caused by a mutation in troponin T1. Am J Hum Genet (2000) 1.84

Autosomal dominant transmission of the Pallister-Hall syndrome. J Pediatr (1993) 1.83

Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nat Genet (1996) 1.82

Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant. J Pediatr (1992) 1.82

Genetic heterogeneity in families with hereditary multiple exostoses. Am J Hum Genet (1993) 1.77

Effect of the contraceptive sponge on chlamydial infection, gonorrhea, and candidiasis. A comparative clinical trial. JAMA (1987) 1.75

The Marfan syndrome locus: confirmation of assignment to chromosome 15 and identification of tightly linked markers at 15q15-q21.3. Genomics (1991) 1.75

Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Am J Hum Genet (1998) 1.72

Clustering of fibrillin (FBN1) missense mutations in Marfan syndrome patients at cysteine residues in EGF-like domains. Hum Mutat (1992) 1.71

Marfan phenotype variability in a family segregating a missense mutation in the epidermal growth factor-like motif of the fibrillin gene. J Clin Invest (1992) 1.68

A type X collagen mutation causes Schmid metaphyseal chondrodysplasia. Nat Genet (1993) 1.67

Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat Genet (1999) 1.67

GLI3 mutations in human disorders mimic Drosophila cubitus interruptus protein functions and localization. Proc Natl Acad Sci U S A (1999) 1.63

Association study of transforming growth factor alpha (TGF alpha) TaqI polymorphism and oral clefts: indication of gene-environment interaction in a population-based sample of infants with birth defects. Am J Epidemiol (1995) 1.62

Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype. Am J Hum Genet (2000) 1.58

Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7. Proc Natl Acad Sci U S A (1995) 1.58

Characterisation and subunit structures of the vicilin storage proteins of pea (Pisum sativum L.). Eur J Biochem (1981) 1.58

Mutation analysis of LMX1B gene in nail-patella syndrome patients. Am J Hum Genet (1998) 1.49

A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos. Hum Mol Genet (2000) 1.46

High-resolution linkage-disequilibrium mapping of the cartilage-hair hypoplasia gene. Am J Hum Genet (1994) 1.45

Sudden death caused by pulmonary thromboembolism in Proteus syndrome. Clin Genet (2000) 1.44

Molecular analysis of the 18q- syndrome--and correlation with phenotype. Am J Hum Genet (1993) 1.40

Prevalence of Pro250Arg mutation of fibroblast growth factor receptor 3 in coronal craniosynostosis. Lancet (1997) 1.40

A study of linkage and association of body mass index in the Old Order Amish. Am J Med Genet C Semin Med Genet (2003) 1.38

Phenotypic overlap of McKusick-Kaufman syndrome with bardet-biedl syndrome: a literature review. Am J Med Genet (2000) 1.37

Marfan syndrome: no evidence for heterogeneity in different populations, and more precise mapping of the gene. Am J Hum Genet (1991) 1.35

A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene. Am J Hum Genet (1999) 1.35

Isolation of the human chromosome 22q telomere and its application to detection of cryptic chromosomal abnormalities. Hum Genet (1996) 1.33

Mortality in achondroplasia. Am J Hum Genet (1987) 1.33

Smoking and reproduction. Fertil Steril (1986) 1.32

Parental attitudes, values, and beliefs toward the return of results from exome sequencing in children. Clin Genet (2013) 1.31

Maternal and abortion related deaths in Bangladesh, 1978-1979. Int J Gynaecol Obstet (1981) 1.27

The purification of early-pregnancy factor to homogeneity from human platelets and identification as chaperonin 10. Eur J Biochem (1994) 1.26

An early pregnancy factor detected in human serum by the rosette inhibition test. Lancet (1977) 1.26

Immunosuppression detected in pregnant mice by rosette inhibition test. Nature (1974) 1.25

Studies of the rosette inhibition test in pregnant mice: evidence of immunosuppression? Proc R Soc Lond B Biol Sci (1976) 1.23

Effects of informed consent for individual genome sequencing on relevant knowledge. Clin Genet (2012) 1.20

An exclusion map of Marfan syndrome. J Med Genet (1990) 1.18

The gene for the Ellis-van Creveld syndrome is located on chromosome 4p16. Genomics (1996) 1.17

Mutation analysis of the MKKS gene in McKusick-Kaufman syndrome and selected Bardet-Biedl syndrome patients. Hum Genet (2002) 1.14

Agreement between women's histories of oral contraceptive use and physician records. Int J Epidemiol (1983) 1.14

Unfolding the role of chaperones and chaperonins in human disease. Trends Genet (2001) 1.14

Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice. Hum Mol Genet (2001) 1.13

Occupational influences on reproduction: a review of recent literature. J Occup Med (1987) 1.12

The association of depo-medroxyprogesterone acetate and breast cancer. Contraception (1980) 1.12

Thoracolumbar spinal abnormalities in Stickler syndrome. Spine (Phila Pa 1976) (2001) 1.11

Jeune asphyxiating thoracic dystrophy and short-rib polydactyly type III (Verma-Naumoff) are variants of the same disorder. Am J Med Genet (2000) 1.10

Strike three for GLI3. Nat Genet (1997) 1.10

Early pregnancy factor is immunosuppressive. Nature (1979) 1.09

PTEN mutations and proteus syndrome. Lancet (2001) 1.09

Puerperal endometritis: a prospective microbiologic study. Am J Obstet Gynecol (1975) 1.08

Multiple molecular mechanisms underlying subdiagnostic variants of Marfan syndrome. Am J Hum Genet (1998) 1.07

Interrelationship between poly (ADP-Rib) synthesis, intracellular NAD levels, and muscle or cartilage differentiation from mesodermal cells of embryonic chick limb. Proc Natl Acad Sci U S A (1975) 1.07

Molecular genetic analysis in autosomal dominant keratoconus. Cornea (1992) 1.07

Towards a complete North American Anabaptist genealogy: A systematic approach to merging partially overlapping genealogy resources. Am J Med Genet (1999) 1.06

DNA light on the Tegernsee giant. Lancet (1991) 1.05

Parental attitudes toward a diagnosis in children with unidentified multiple congenital anomaly syndromes. Am J Med Genet (2001) 1.05

Linkage of typical pseudoachondroplasia to chromosome 19. Genomics (1993) 1.05

A nonsense mutation in the cathepsin K gene observed in a family with pycnodysostosis. Genome Res (1996) 1.04

Fine mapping of the nail-patella syndrome locus at 9q34. Am J Hum Genet (1997) 1.03

Sleep-disordered breathing in children with achondroplasia. J Pediatr (1998) 1.02

Determination of the allelic frequency in Smith-Lemli-Opitz syndrome by analysis of massively parallel sequencing data sets. Clin Genet (2014) 1.02

Detection and separation of two serum factors responsible for depression of lymphocyte activity in pregnancy. Clin Exp Immunol (1978) 1.00

Therapeutic approaches to cobalamin-C methylmalonic acidemia and homocystinuria. J Pediatr (1988) 1.00

Diagnosis of X-linked adrenal hypoplasia congenita by mutation analysis of the DAX1 gene. JAMA (1995) 0.99

Pycnodysostosis: orofacial manifestations in two pediatric patients. Pediatr Dent (1998) 0.99

Detection of an early pregnancy factor-like substance in sera of patients with testicular germ cell tumors. Am J Reprod Immunol (1983) 0.98

COL5A1: fine genetic mapping and exclusion as candidate gene in families with nail-patella syndrome, tuberous sclerosis 1, hereditary hemorrhagic telangiectasia, and Ehlers-Danlos Syndrome type II. Genomics (1995) 0.98

Antibodies to early pregnancy factor retard embryonic development in mice in vivo. J Reprod Fertil (1991) 0.98

Identification of nine novel mutations in cartilage oligomeric matrix protein in patients with pseudoachondroplasia and multiple epiphyseal dysplasia. Am J Med Genet (1999) 0.96

Overlap of PIV syndrome, VACTERL and Pallister-Hall syndrome: clinical and molecular analysis. Clin Genet (2000) 0.95

A comparison of the Berlin and Ghent nosologies and the influence of dural ectasia in the diagnosis of Marfan syndrome. Genet Med (2001) 0.95

Monoclonal antibodies to early pregnancy factor perturb tumour cell growth. Clin Exp Immunol (1990) 0.95

Key role for a minor collagen. Nat Genet (1995) 0.95

Report from the Maryland Epidemiology Schizophrenia Linkage Study: no evidence for linkage between schizophrenia and a number of candidate and other genomic regions using a complex dominant model. Am J Med Genet (1994) 0.95